Kawasaki Syndrome is endemic i n -~a w a i i with s t e a d i l y increasing yearly incidence and a t o t a l of 132 cases studied prospect i v e l y : 20% c a r d i t i s , 17% coronary aneurysms, 33% a r t h r i t i s . B a c t e r i a l c u l t u r e s from blood (82), noselthroat (76), eyes (12), s t o o l (60), urine (84), vagina ( l o ) , and CSF (48) have been s t e ri l e o r + normal f l o r a . Staphylococci found only i n 21% t h r o a t ,
1 % s t o o l , no f o c a l i n f e c t i o n s . Leptospiral stildies -blood, urine negative 43, 0124 s e r o l o g i c response. V i r a l and chlamydia1 i s o l a t i o n s 74 p a t i e n t s + 4 i s o l a t e s : RSV-like, CMV, adenovirus, coxsakie B. Electron microscopy of s t o o l , urine, serum, throat washings f t i n f e c t i o u s p a r t i c l e s even when stained with convalescent serum. Paired s e r a f t seroconversion t o l e g i o n e l l a , CMV, EB, influenza, parainfluenza, rubeola, r u b e l l a , v a r i c e l l a , mycoplasma, pneumoniae, chlamydia, or r i c k e t t s i a e . CF antibody rose t o adenovirus i n 6/52 and n e u t r a l i z i n g antibody t o RSV-like v i r u s developed i n 4/40. IgE r o s e , peaked i n week I1 & 111, f e l l i n 27/34. Immune complexes found i n weeks I1 & 111 i n p a t i e n t s with c a r d i t i s / a r t h r i t i s . Epidemiolwgy: Ma1e:female 1.6:l. Peak age 6 mo-2 years (range 6 weeks-8 years). Sharply defined epidemics of 32 and 25 cases noted i n February-June 1978, October-May 1979-80. Ethnic p r e d i l e c t i o n : Japanese overrepresentation; Caucas i a n s , F i l i p i n o s underrepresented. Secondary cases : 2/97 exposed s i b l i n g s , O/s400 day care contacts. URI within 1 no. onset: 62% cases vs 57% controls. C l i n i c a l , immunologic, epidemiologic f e a t u r e s suggest acute i n f e c t i o u s t r i g g e r t o immunologically mediated generalized v a s c u l i t i s .
INNATE,INTERFERON (IFN) MEDIATED,CELLULAR RESISTANCE TO MOUSE CYTOMEGALOVIRUS (MCMV) DEMONSTRATED I N EMBRYO
FIBROBLAST CULTURES (MECC) . Donald N. Medearis, J r . , Thomas A. Kelly, Mass. General Hospital, Children's Service,Boston
Our goal was t o help define host r e s i s t a n c e t o MCMV. M C M V killing of CBA, C3H. BALB/c and C57B16 weanlings was compared t o M C M V multiplication i n secondary MECC prepared from t h e s e mousestrains, W e know t h a t o t h e r s have not found differences i n MECC responseto MCMV, and differences we saw were small. A 10% w/v s a l i v a r y gland homogenate harvested from CD-1 weanling mice 3 wks a f t e r IP inocw l a t i o n was u t i l i z e d a s MCMV. In a representative experiment 106 PFU M C M V IP k i l l e d none of t h e CBA and C3H mice, but ~O O % O~B A L B / C and 40% of C57's. The number (av. of 10 p l a t e s ) and s i z e (av. of 50) of plaques produced on the various MECC were: CBA 77 plaques, av. s i z e 0.3 mm; C3H 142, 0.3; C57B16 116, 0.5; BALB/c 150, 0.6. Several experiments comparing only CBA and BALBlc mice and MECC ( t h e most and l e a s t r e s i s t a n t i n vivo and i n v i t r o ) confirmed these r e s u l t s . M C M V growth was more (5 f o l d ) i n BALB/c thaninCBA MECC and cytopathology was somewhat g r e a t e r . The s e n s i t i v i t y of CBA and BALB/c MECC t o IFN and an IFN inducer was then determined IFN (Cal Biochem) reduced MCMV growth s l i g h t l y (3-10 fold) nurein CBA than i n BALB/c MECC. When Poly(I).Poly(C) (P.L. Biochemicals) lOug/dish was used t o induce IFN, M C M V growth was reduced much more i n CBA than i n BALB/c MECC: 6 d post-inoc of 100 PFU, BALB/c had 55 x lo3 PFU/ml and CBA 76 x 101. These r e s u l t s i n d i c a t e t h a t r e s i s t a n c e t o M C M V i s conferred i n part by an i n n a t e , probably genetically determined, non-immune c e l l u l a r r e s i s t a n c e which can During a community outbreak o f enterovirus infection, 7 o f 194 (3.6%) pregnant women were found t o be excreting a prime s t r a i n o f echovirus 11 a t term. Each o f the 7 v i r u s p o s i t i v e women possessed serum n e u t r a l i z i n g echovirus 11 antibody a t d e l i v e r y i n t i t e r s ranging from 1:20 t o 1:320, and the cord sera o f the 7 i n f a n t s born t o these mothers also had antibody i n t it e r s o f 1:10 t o 1:640. The 7 i n f a n t s o f these women d i d not become i l l , but 4 shed v i r u s from t h e r e s p i r a t o r y and/or gastroi n t e s t i n a l t r a c t by three days o f age. None o f the i n f a n t s o f v i r u s negative mothers cultured a t hospital discharge (151 i nfants), o r a t two weeks o f age (135 i n f a n t s ) , became infected, I n comparison, a previously reported group o f 4 i n f a n t s who died o f generalized i n f e c t i o n due t o the same s t r a i n o f echovirus 11 d i d not have detectable cord antibody.
We conclude t h a t passively acquired, transplacental a n t i body prevents severe, systemic echovirus disease, but does not prevent mucosal i n f e c t i o n o f the p e r i n a t a l l y infected i n f a n t . Our experience also indicates t h a t i n f a n t s born t o mothers who become infected w i t h an enterovirus w i t h i n the l a s t week o f pregnancy are a t r i s k o f serious perinatal disease.
RAPID VIRAL DIAGNOSIS I N AN OUTPATIENT LABORATORY.
M.D. Mur h and G. Macias (Spon. by P. Brunell), UTHSC, D:pYrtment of P e d i a t r i c s , San Antonio, Texas.
Making a s p e c i f i c v i r a l diagnosis is limited by the time, expense and e x p e r t i s e required. Recent developments i n t h e a r e a of rapid v i r a l diagnosis, Enzyme Linked Immuno Sorbent Assay (ELISA), have surmounted these d i f f i c u l t i e s . ELISA requires no expensive equipment and provides an answer i n hours. In research laborator i e s the s p e c i f i c i t y and s e n s i t i v i t y of ELISA i n i d e n t i f i c a t i o n of Rotavirus (RV) has been demonstrated. Studies have shown t h a t over 50% of children hospitalized with dehydration from diarrhea i n t h e winter excrete r o t a v i r u s while the prevalence of r o t a v i r u s i n ambulatory p a t i e n t s with diarrhea is l e s s than 15%. Therefore, an o u t p a t i e n t with diarrhea and excreting r o t a v i r u s is a t high r i s k f o r dehydration.
W e a r e evaluating the a p p l i c a b i l i t y of ELISA i n a p e d i a t r i c outpatient (POP) l a b which r o 6 t i n e l y performs limited o f f i c e procedures. A laboratory technician (MLT) performed a l l procedures. To t e s t the a b i l i t y of an MLT t o accurately perform ELISA f o r RV, s t o o l samples known t o be (+) o r (-) f o r R V by EM and ELISA, were b l i n d l y submitted with other s t o o l specimens t o the laboratory. The ELISA procedure was performed on 87 specimens: 69 c l i n i c a l specimens and 18 "unknown" specimens. There were 1 3 p o s i t i v e c l i n i c a l samples and 16 of the 18 unknowns were c o r r e c t l y i n t e rpreted. The e n t i r e procedure requires 6 hr/45 min. Actual MLT time was 1 hr/45 min. Rapid Viral Diagnosis could become an inexpensive a v a i l a b l e technique f o r o u t p a t i e n t diagnosis. Rotav i r u s ELISA could be useful i n i d e n t i f y i n g children a t high r i s k f o r dehydration. Texas. D e~t . o f Pediatrics. A t r i a l was designed t o determine the antigen and adjuvant composition f o r pertussis vaccine which would produce the l e a s t reactogenicity and the best antibody response (ABR). DPT preparations containing f l u i d (F) o r whole c e l l (W) pertussis a n t igen and e i t h e r alum (U) o r AlPO4 (P) adjuvant were compared. Serologic data were collected on 42 patients; reactogenicity was assessed following 263 doses.
Although whole c e l l antigen produced a greater ABR i t also resulted i n increased f e b r i l e responses. Fever tended t o be greater w i t h increasing number o f immunizations. 
